Remote monitoring program for ADHD in rural children
A Pilot Study of a Remote Attention-Deficit/Hyperactivity Disorder Monitoring Program (RAMP) for Children in Rural Areas
This study is testing a new remote monitoring program for children with ADHD in rural areas to see if it helps caregivers report symptoms better than just using standard educational materials.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 36 (estimated) |
| Ages | 5 Years to 11 Years |
| Sex | All |
| Sponsor | IDeA States Pediatric Clinical Trials Network Research network |
| Locations | 2 sites (Jackson, Mississippi and 1 other locations) |
| Trial ID | NCT06743425 on ClinicalTrials.gov |
What this trial studies
The RAMP program is a pilot initiative aimed at evaluating the feasibility of a remote monitoring system for children aged 5-11 diagnosed with ADHD in rural areas. This study will enroll 36 caregiver-child dyads across two sites, where participants will be randomized to either receive text-based symptom reporting prompts or standard digital education handouts. The program includes ADHD Best Practice education for providers and utilizes the Vanderbilt Rating Scales for symptom assessment. The study will last for 10 months, focusing on the implementation and engagement of the monitoring program rather than clinical outcomes.
Who should consider this trial
Good fit: Ideal candidates are children aged 5-11 with a diagnosis of ADHD who are starting stimulant medication for the first time or have not received it in the last six months.
Not a fit: Patients with serious mental health comorbidities or those not residing with their caregiver at least three days a week may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could enhance the management of ADHD symptoms in rural children through improved monitoring and communication.
How similar studies have performed: While this approach is innovative, similar studies have shown promise in using remote monitoring for chronic conditions, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: The child must * be under the care of a participating provider * be aged 5-11 at enrollment * have a diagnosis of ADHD * be initiating stimulant medication for treatment for the first time or have not received stimulant medication for the last 6 months * be attending in-person elementary school The Primary caregiver must * be willing and legally able to give consent * have access to a smartphone * be English-speaking * reside with the child at least 3 days per week * complete an initial symptom assessment prior to starting stimulant treatment and be willing to provide a copy to the study team The provider must * manage ADHD care in patients age 5-11 years * provide informed consent * agree to use the RAMP platform if they care for patients randomized to use it * agree to provide information to potential participants about the study and contact the research coordinator if interested Exclusion Criteria: Child: * has serious mental health comorbidities (Children with depression, anxiety, oppositional defiant disorder will be permitted to participate. Children with schizophrenia, bipolar disorder, conduct disorder and those who have been hospitalized for any mental health condition will be excluded from the study.) * has severe neurodevelopment disorders (Children with well-controlled seizure disorders will be permitted to participate.) * is currently receiving, or previously received, atypical antipsychotic medication treatment * is or becomes pregnant
Where this trial is running
Jackson, Mississippi and 1 other locations
- University of Mississippi Medical Center — Jackson, Mississippi, United States (Recruiting)
- Medical University of South Carolina — Charleston, South Carolina, United States (Recruiting)
Study contacts
- Study coordinator: Song Ounpraseuth, PhD
- Email: STOunpraseuth@uams.edu
- Phone: 501-686-7233
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.